Class 1 Auto-Approval: What the January 2025 TFDA Change Means for Your Market Entry

In January 2025, the TFDA implemented a significant change to its Class 1 medical device registration pathway: auto-approval for devices appearing on the Positive List. For qualifying products this compressed registration timelines from several months to three to five business days, making it one of the most practically significant efficiency improvements for foreign manufacturers targeting Thailand in recent years.

What Auto-Approval Actually Means

Auto-approval means that a Class 1 medical device application for a device on the Positive List is processed through an automated system check in the TFDA's e-submission platform rather than entering a manual review queue. If the application is complete and the device matches Positive List criteria, registration is issued without human review, typically within three to five business days. The value is entirely in the timeline. Application documentation requirements are identical to a standard Class 1 submission — auto-approval does not mean simplified or reduced requirements.

What the Positive List Is

The Positive List is a TFDA-maintained catalogue of medical device categories, identified by GMDN codes, that qualify for the auto-approval pathway. Inclusion criteria are based on risk profile, absence of novel technology or novel intended use, and international regulatory status. The Positive List requires valid approval from a recognized reference jurisdiction — US FDA, CE Mark, PMDA, or TGA — as a prerequisite for inclusion. Not all Class 1 devices qualify: devices with novel technologies, novel intended uses, or specific safety concerns may be Class 1 by Thai classification but still require full manual review outside the Positive List pathway. The list is updated periodically, so current eligibility must be confirmed before submission preparation begins.

What the Application Requires

An auto-approval application submitted through the TFDA's e-submission system must include all standard Class 1 required elements: manufacturer details and facility information, device description and intended use, technical documentation and Declaration of Conformity, free sale certificates from the country of manufacture, Thai-compliant labeling, and applicable testing data where required. The automated system validates completeness against Positive List criteria. An incomplete application will not pass the check and will require resubmission, resetting the clock.

How This Compares Across ASEAN

For manufacturers evaluating Thailand against other ASEAN markets, the auto-approval pathway represents a meaningful competitive advantage for Class 1 product lines. Comparable auto-approval mechanisms do not exist for most Class 1 categories in Indonesia, Vietnam, or the Philippines, where manual review timelines typically run 3 to 12 months. Thailand's January 2025 change makes it one of the most efficient Class 1 registration environments in the region. For manufacturers with multiple Class 1 products, the aggregate time saving across a portfolio can be substantial relative to alternative ASEAN registration strategies.

Common Errors That Delay Auto-Approval

The most frequent causes of auto-approval failure are: Positive List eligibility assessment done against an outdated version of the list, since TFDA updates it periodically; incomplete free sale certificate documentation that does not precisely match the device description in the technical dossier; labeling that does not comply with the December 2025 labeling regulation (B.E. 2568) effective June 20, 2026; and device classification that was performed without confirming current TFDA interpretation of AMDD rules for the specific device type. DeeMED Consulting manages Class 1 registration applications for foreign manufacturers, including current Positive List eligibility assessment, application preparation, and e-submission filing.